Developer docs
API playgroundTry for free, no card

Search company profiles

DIVASA-FARMAVIC

Full company profile

uuid000ejqe

Namestring
DIVASA-FARMAVIC
Legal namestring
DIVASA-FARMAVIC, S.A.
Company typeenum
Private
Founded yearint
1970
Descriptiontext

DIVASA-FARMAVIC, S.A. (trading as DFV Group) is a Spanish private veterinary pharmaceutical company headquartered in Gurb-Vic (Vic), Spain. The group organizes its activities into three functions: production via several plants using advanced manufacturing technology; development through multiple R&D teams that adapt formulations to changing regulatory requirements; and marketing through a combination of wholly-owned subsidiaries and external distributor networks. Core revenue streams include veterinary pharmaceuticals (anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements), the DFV Test line of immunochromatographic rapid diagnostic tests for in-clinic disease detection, veterinary instruments, and contract manufacturing services for third-party veterinary pharmaceutical companies.

The company's technical differentiation rests on three proprietary platforms. First, DFV® Protect technology uses specifically selected microalgae extracts with anti-adherent properties to produce dermatological products that prevent microorganism adhesion to animal skin. Second, several patented oral formulations deliver water-soluble solutions with superior stability and efficacy across different water types. Third, the DFV® Test line provides rapid in-clinic diagnostics for Giardia, Parvo/Corona, Dirofilaria, FeLV/FIV, Leishmania, Ehrlichia, and Anaplasma, developed through university-supported biotechnology research. Sub-brands include DFV Derm (dermatology), DFV Test (diagnostics), Taberdog (anti-parasitic collars and shampoos), and Tabernil (ornamental bird products).

DFV operates a multi-channel go-to-market model: direct sales in Spain, wholly-owned subsidiaries in Ecuador, Portugal, Venezuela, and Mexico managing local distribution with dedicated sales teams, and authorized distributor networks reaching more than 60 countries across Europe, Africa, Asia, the Middle East, and the Americas. The company is sales-led, supported by trade show participation (CPhI, EuroTier, VIV Asia, ANEMBE, GEDA), a WhatsApp-based technical support service for veterinary professionals, and a dedicated contract manufacturing brand marketed through CPhI. Customer segments are veterinary professionals, companion animal owners, and livestock operations. The company is EU GMP certified and holds dedicated pharmacovigilance and data protection functions, indicating regulatory maturity for multi-jurisdiction veterinary pharmaceutical distribution.

Short descriptiontext

DIVASA-FARMAVIC (DFV Group) is a Spanish private veterinary pharmaceutical manufacturer producing pharmaceuticals, immunochromatographic rapid diagnostic tests, and dermatological products for veterinary professionals, companion animal owners, and livestock operations across 60+ countries via subsidiaries and distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGurb, Spain
HQ citystring
Gurb
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary pharmaceuticals, animal health products, veterinary diagnostic tests, veterinary dermatology products, contract manufacturing
Industry3 codes
PRIMARYHLAMAEAB
Livestock & Production Animal Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYAFACADAF
Diagnostics & Laboratory Services (Sampling, Necropsy, Disease Investigation)
SECONDARYAFAEANAK
Veterinary Pharmacy, Vaccine & Biologics Services
NAICS code1 code
  • Veterinary Services54194
SIC code2 codes
  • Pharmaceutical Preparations2834
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Veterinary Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Veterinary Pharmaceuticals
TypeOne Time License
Description

Production and sale of pharmaceutical products for animals including anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements, and circulatory/metabolic regulators for companion animals and production livestock.

divasa-farmavic.com
2Rapid Diagnostic Tests
TypeOne Time License
Description

Sale of immunochromatographic diagnostic tests (DFV® TEST line) for veterinary clinics to detect diseases in pets and production animals. Tests are sold in various packaging formats (individual units, clinical packs).

divasa-farmavic.com
3Veterinary Instruments
TypeOne Time License
Description

Development and sale of veterinary instruments and equipment adapted for clinical field use, featuring reliable, precise, long-lasting, and easy-to-use products.

divasa-farmavic.com
4Contract Manufacturing
TypeProfessional Services
Description

Third-party manufacturing services for the veterinary pharmaceutical sector through dedicated website dfv-contractmanufacturing.com. The company positions itself as a reference for contract manufacturing in the veterinary sector, participating in CPhI to expand this business.

divasa-farmavic.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1DFV DERM
Description

Dermatological product line for animals with DFV Protect technology

divasa-farmavic.com
+3 more records
Core offering1 text field

DIVASA-FARMAVIC (DFV® Group) manufactures and sells veterinary pharmaceutical products for companion animals and production livestock, including anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements, and metabolic regulators. The group also produces immunochromatographic rapid diagnostic tests (DFV® Test line), veterinary instruments, and contract manufacturing services for the veterinary pharmaceutical sector.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

DIVASA-FARMAVIC (DFV Group) is an animal health and welfare company operating across four main segments: companion animals (pets), production animals (livestock), veterinary diagnostics, and contract manufacturing. The product portfolio includes the DFV Test line of immunochromatographic rapid diagnostic tests for pets, the DFV Derm dermatological line featuring proprietary microalgae extract technology (DFV Protect), the Taberdog and Tabernil external antiparasitic product lines, equine products (Hyaludol, Equitech Butazona), and Aerofar wound treatment. The company offers contract manufacturing services for the veterinary pharmaceutical sector.

Product and service8 records
1DFV Test Line
CategoryVeterinary Diagnostics
Description

Immunochromatographic rapid in-clinic diagnostic tests for detection of antigens and antibodies in pets, including Giardia, Dirofilaria (Heartworm), FeLV, FIV, Leishmania, Ehrlichia, Anaplasma, and Parvo/Corona. Designed for veterinary clinics to obtain timely disease detection results.

2DFV Derm Line
CategoryVeterinary Dermatology
Description

Dermatological products for pets featuring DFV® Protect technology using microalgae extracts with anti-adherent properties. Includes shampoos (Sensitive A1, Seborrea S1, PrO P1), otic lotion (O1), and display units for veterinary clinics.

3Taberdog Line
CategoryVeterinary Antiparasitics
Description

External antiparasitic products for dogs including medicated collars (Dimpilato and Permetrina) and shampoo (Tetrametrina + BP) for protection against fleas, ticks, flies, and mosquitoes.

4Tabernil Line
CategoryVeterinary Supplements and Antiparasitics
Description

Products for ornamental birds including vitamin supplements (AD3E, complejo B), breeding aids (Cría), doxycycline treatment, spray insecticide (Tetrametrina + Piperonyl butoxide), and molting support (muda).

5Hyaludol
CategoryEquine Veterinary Pharmaceuticals
Description

Hyaluronic acid product with superior viscoelasticity for reactivation of joint functions in competition horses. Presented as individual pack containing 1 syringe of 3ml.

6Equitech Butazona
CategoryEquine Veterinary Pharmaceuticals
Description

Oral granular phenylbutazone with anti-inflammatory and analgesic effect for horses. Commercial presentation in boxes containing 20 sachets of 5g.

7Aerofar
CategoryVeterinary Wound Care
Description

Cutaneous aerosol suspension containing chlortetracycline hydrochloride for treatment of superficial wounds in animals. Indicated for surgical wounds, superficial wounds, and podal infections. 335ml container (250g product).

8Contract Manufacturing Services
CategoryContract Manufacturing Services
Description

Contract manufacturing services for the veterinary pharmaceutical sector. The company participates in CPhI Worldwide as a reference for contract manufacturing in the veterinary sector, leveraging its EU GMP-certified manufacturing plants.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Meiji
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-01
Description

Meiji, along with Emdoka, visited DFV facilities in September 2024 for working sessions to strengthen existing collaboration between the three companies.

divasa-farmavic.com
2Emdoka
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-01
Description

Emdoka, along with Meiji, visited DFV facilities in September 2024 for working sessions to strengthen existing collaboration between the three companies.

divasa-farmavic.com
Strategic tierMinorTypeOthers
Description

Social economy company providing workplace insertion for people with disabilities. Partnered with DFV for preparing product displays with new color references for TABERDOG® COLLAR PERMETRINA. DFV contributes to job insertion of people with disabilities through this collaboration.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Independent global veterinary pharmaceutical company headquartered in France with a similar mid-sized, multi-species product portfolio spanning companion and production animals. Highly comparable segment scope and commercial model.

TypeDirect peer
Description

French veterinary pharmaceutical group with comparable companion/livestock pharma and diagnostics portfolio. Both are privately anchored, mid-tier independent players competing against the multinational majors.

TypeDirect peer
Description

Independent French veterinary pharma company with strong livestock and emerging market presence. Directly comparable mix of pharmaceuticals, vaccines, and diagnostic devices targeting similar customers.

TypeDirect peer
Description

Spanish veterinary pharmaceutical and biological company headquartered in Catalonia. National direct competitor with overlapping product categories (vaccines, pharmaceuticals, diagnostics) and similar mid-sized private profile.

TypeDirect peer
Description

UK-based veterinary pharmaceutical company specializing in companion and production animal therapeutics. Comparable in portfolio breadth across species and therapeutic categories.

TypeDirect peer
Description

Privately held Northern Irish veterinary pharmaceutical manufacturer with strong anti-infective and anti-parasitic portfolio. Comparable mid-size independent positioning with manufacturing focus.

TypeBroad incumbent
Description

Global animal health leader with extensive veterinary pharmaceutical, vaccine, and diagnostic portfolio across all species. Represents the dominant competitive incumbent whose scale and R&D budget frame DFV's competitive constraints.

TypeBroad incumbent
Description

Major multinational animal health company with broad pharmaceutical and diagnostic portfolio. Operates within the same veterinary channel but at significantly larger scale and R&D intensity.

9Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Animal health division of Boehringer Ingelheim offering vaccines, pharmaceuticals, and diagnostics. Overlaps with DFV in companion and livestock therapeutics and competes in the same veterinary channel.

TypeDirect peer
Description

Diversified animal health and nutrition company with strong livestock pharmaceutical and nutritional supplement portfolio. Directly comparable in production animal pharma and nutritional supplement segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DIVASA-FARMAVIC

Veterinary Pharmaceuticalsdivasa-farmavic.com

DIVASA-FARMAVIC (DFV Group) is a Spanish private veterinary pharmaceutical manufacturer producing pharmaceuticals, immunochromatographic rapid diagnostic tests, and dermatological products for veterinary professionals, companion animal owners, and livestock operations across 60+ countries via subsidiaries and distributors.

What DIVASA-FARMAVIC does

DIVASA-FARMAVIC, S.A. (trading as DFV Group) is a Spanish private veterinary pharmaceutical company headquartered in Gurb-Vic (Vic), Spain. The group organizes its activities into three functions: production via several plants using advanced manufacturing technology; development through multiple R&D teams that adapt formulations to changing regulatory requirements; and marketing through a combination of wholly-owned subsidiaries and external distributor networks. Core revenue streams include veterinary pharmaceuticals (anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements), the DFV Test line of immunochromatographic rapid diagnostic tests for in-clinic disease detection, veterinary instruments, and contract manufacturing services for third-party veterinary pharmaceutical companies.

The company's technical differentiation rests on three proprietary platforms. First, DFV® Protect technology uses specifically selected microalgae extracts with anti-adherent properties to produce dermatological products that prevent microorganism adhesion to animal skin. Second, several patented oral formulations deliver water-soluble solutions with superior stability and efficacy across different water types. Third, the DFV® Test line provides rapid in-clinic diagnostics for Giardia, Parvo/Corona, Dirofilaria, FeLV/FIV, Leishmania, Ehrlichia, and Anaplasma, developed through university-supported biotechnology research. Sub-brands include DFV Derm (dermatology), DFV Test (diagnostics), Taberdog (anti-parasitic collars and shampoos), and Tabernil (ornamental bird products).

DFV operates a multi-channel go-to-market model: direct sales in Spain, wholly-owned subsidiaries in Ecuador, Portugal, Venezuela, and Mexico managing local distribution with dedicated sales teams, and authorized distributor networks reaching more than 60 countries across Europe, Africa, Asia, the Middle East, and the Americas. The company is sales-led, supported by trade show participation (CPhI, EuroTier, VIV Asia, ANEMBE, GEDA), a WhatsApp-based technical support service for veterinary professionals, and a dedicated contract manufacturing brand marketed through CPhI. Customer segments are veterinary professionals, companion animal owners, and livestock operations. The company is EU GMP certified and holds dedicated pharmacovigilance and data protection functions, indicating regulatory maturity for multi-jurisdiction veterinary pharmaceutical distribution.

DIVASA-FARMAVIC firmographics

Firmographics
Name
DIVASA-FARMAVIC
Legal name
DIVASA-FARMAVIC, S.A.
Website
https://divasa-farmavic.com
Company type
Private
Founded year
1970
Operating status
Operating
Headcount range
11–50 employees
Short description
DIVASA-FARMAVIC (DFV Group) is a Spanish private veterinary pharmaceutical manufacturer producing pharmaceuticals, immunochromatographic rapid diagnostic tests, and dermatological products for veterinary professionals, companion animal owners, and livestock operations across 60+ countries via subsidiaries and distributors.
Ownership category
akta.pro rank

DIVASA-FARMAVIC industry classification

Industry
Product category
Veterinary Pharmaceuticals
NAICS
Veterinary Services (54194)
SIC
Pharmaceutical Preparations (2834), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAMAEAB
Livestock & Production Animal Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYAFACADAF
Diagnostics & Laboratory Services (Sampling, Necropsy, Disease Investigation)
SECONDARYAFAEANAK
Veterinary Pharmacy, Vaccine & Biologics Services

Keywords

  • Veterinary pharmaceuticals
  • Animal health products
  • Veterinary diagnostic tests
  • Veterinary dermatology products
  • Contract manufacturing

Where DIVASA-FARMAVIC is headquartered

Location

Headquarters

HQ city
Gurb
HQ country
Spain
HQ region
Europe

Offices5 records

Markets served

DIVASA-FARMAVIC business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Veterinary Pharmaceuticals: Production and sale of pharmaceutical products for animals including anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements, and circulatory/metabolic regulators for companion animals and production livestock.
  2. Rapid Diagnostic Tests: Sale of immunochromatographic diagnostic tests (DFV® TEST line) for veterinary clinics to detect diseases in pets and production animals. Tests are sold in various packaging formats (individual units, clinical packs).
  3. Veterinary Instruments: Development and sale of veterinary instruments and equipment adapted for clinical field use, featuring reliable, precise, long-lasting, and easy-to-use products.
  4. Contract Manufacturing: Third-party manufacturing services for the veterinary pharmaceutical sector through dedicated website dfv-contractmanufacturing.com. The company positions itself as a reference for contract manufacturing in the veterinary sector, participating in CPhI to expand this business.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

DIVASA-FARMAVIC product offering

Product offering

Core offering

DIVASA-FARMAVIC (DFV® Group) manufactures and sells veterinary pharmaceutical products for companion animals and production livestock, including anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements, and metabolic regulators. The group also produces immunochromatographic rapid diagnostic tests (DFV® Test line), veterinary instruments, and contract manufacturing services for the veterinary pharmaceutical sector.

Product overview

DIVASA-FARMAVIC (DFV Group) is an animal health and welfare company operating across four main segments: companion animals (pets), production animals (livestock), veterinary diagnostics, and contract manufacturing. The product portfolio includes the DFV Test line of immunochromatographic rapid diagnostic tests for pets, the DFV Derm dermatological line featuring proprietary microalgae extract technology (DFV Protect), the Taberdog and Tabernil external antiparasitic product lines, equine products (Hyaludol, Equitech Butazona), and Aerofar wound treatment. The company offers contract manufacturing services for the veterinary pharmaceutical sector.

Differentiator

Problem solved

Functional benefit

Brands

  • DFV DERM: Dermatological product line for animals with DFV Protect technology
  • DFV Test
  • Taberdog
  • Tabernil

Products and services

  • DFV Test Line Immunochromatographic rapid in-clinic diagnostic tests for detection of antigens and antibodies in pets, including Giardia, Dirofilaria (Heartworm), FeLV, FIV, Leishmania, Ehrlichia, Anaplasma, and Parvo/Corona. Designed for veterinary clinics to obtain timely disease detection results.
  • DFV Derm Line Dermatological products for pets featuring DFV® Protect technology using microalgae extracts with anti-adherent properties. Includes shampoos (Sensitive A1, Seborrea S1, PrO P1), otic lotion (O1), and display units for veterinary clinics.
  • Taberdog Line External antiparasitic products for dogs including medicated collars (Dimpilato and Permetrina) and shampoo (Tetrametrina + BP) for protection against fleas, ticks, flies, and mosquitoes.
  • Tabernil Line Products for ornamental birds including vitamin supplements (AD3E, complejo B), breeding aids (Cría), doxycycline treatment, spray insecticide (Tetrametrina + Piperonyl butoxide), and molting support (muda).
  • Hyaludol Hyaluronic acid product with superior viscoelasticity for reactivation of joint functions in competition horses. Presented as individual pack containing 1 syringe of 3ml.
  • Equitech Butazona Oral granular phenylbutazone with anti-inflammatory and analgesic effect for horses. Commercial presentation in boxes containing 20 sachets of 5g.
  • Aerofar Cutaneous aerosol suspension containing chlortetracycline hydrochloride for treatment of superficial wounds in animals. Indicated for surgical wounds, superficial wounds, and podal infections. 335ml container (250g product).
  • Contract Manufacturing Services Contract manufacturing services for the veterinary pharmaceutical sector. The company participates in CPhI Worldwide as a reference for contract manufacturing in the veterinary sector, leveraging its EU GMP-certified manufacturing plants.

Companies that use DIVASA-FARMAVIC

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

DIVASA-FARMAVIC technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

DIVASA-FARMAVIC partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • MeijicoreStrategic or Co-development Partner · 1 September 2024Meiji, along with Emdoka, visited DFV facilities in September 2024 for working sessions to strengthen existing collaboration between the three companies.
  • EmdokacoreStrategic or Co-development Partner · 1 September 2024Emdoka, along with Meiji, visited DFV facilities in September 2024 for working sessions to strengthen existing collaboration between the three companies.
  • Tac OsonaminorOthersSocial economy company providing workplace insertion for people with disabilities. Partnered with DFV for preparing product displays with new color references for TABERDOG® COLLAR PERMETRINA. DFV contributes to job insertion of people with disabilities through this collaboration.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

DIVASA-FARMAVIC competitors and assessment

Company assessment

Direct peers

  • Virbac: Independent global veterinary pharmaceutical company headquartered in France with a similar mid-sized, multi-species product portfolio spanning companion and production animals. Highly comparable segment scope and commercial model.
  • Vetoquinol: French veterinary pharmaceutical group with comparable companion/livestock pharma and diagnostics portfolio. Both are privately anchored, mid-tier independent players competing against the multinational majors.
  • Ceva Santé Animale: Independent French veterinary pharma company with strong livestock and emerging market presence. Directly comparable mix of pharmaceuticals, vaccines, and diagnostic devices targeting similar customers.
  • Hipra: Spanish veterinary pharmaceutical and biological company headquartered in Catalonia. National direct competitor with overlapping product categories (vaccines, pharmaceuticals, diagnostics) and similar mid-sized private profile.
  • Dechra Pharmaceuticals: UK-based veterinary pharmaceutical company specializing in companion and production animal therapeutics. Comparable in portfolio breadth across species and therapeutic categories.
  • Norbrook Laboratories: Privately held Northern Irish veterinary pharmaceutical manufacturer with strong anti-infective and anti-parasitic portfolio. Comparable mid-size independent positioning with manufacturing focus.
  • Phibro Animal Health: Diversified animal health and nutrition company with strong livestock pharmaceutical and nutritional supplement portfolio. Directly comparable in production animal pharma and nutritional supplement segments.

Broad incumbents

  • Zoetis: Global animal health leader with extensive veterinary pharmaceutical, vaccine, and diagnostic portfolio across all species. Represents the dominant competitive incumbent whose scale and R&D budget frame DFV's competitive constraints.
  • Elanco Animal Health: Major multinational animal health company with broad pharmaceutical and diagnostic portfolio. Operates within the same veterinary channel but at significantly larger scale and R&D intensity.
  • Boehringer Ingelheim Animal Health: Animal health division of Boehringer Ingelheim offering vaccines, pharmaceuticals, and diagnostics. Overlaps with DFV in companion and livestock therapeutics and competes in the same veterinary channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

DIVASA-FARMAVIC social profiles

Digital presence

DIVASA-FARMAVIC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DIVASA-FARMAVIC leadership team

Management profile

Number of profiles

DIVASA-FARMAVIC subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

DIVASA-FARMAVIC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DIVASA-FARMAVIC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DIVASA-FARMAVIC

What does DIVASA-FARMAVIC do?

DIVASA-FARMAVIC (DFV® Group) manufactures and sells veterinary pharmaceutical products for companion animals and production livestock, including anti-infectives, anti-parasitics, anti-inflammatories, hormonal products, dermatological products, nutritional supplements, and metabolic regulators. The group also produces immunochromatographic rapid diagnostic tests (DFV® Test line), veterinary instruments, and contract manufacturing services for the veterinary pharmaceutical sector.

Is DIVASA-FARMAVIC a public or private company?

DIVASA-FARMAVIC is a private company. It is classified as unknown and is currently operating.

When was DIVASA-FARMAVIC founded?

DIVASA-FARMAVIC was founded in 1970. It employs 11 to 50 people.

Where is DIVASA-FARMAVIC based?

DIVASA-FARMAVIC is headquartered in Gurb, Spain, in the Europe region.

How does DIVASA-FARMAVIC make money?

Four revenue lines are on record. Veterinary Pharmaceuticals are the primary driver. The others are rapid Diagnostic Tests, veterinary Instruments and contract Manufacturing.

Who are DIVASA-FARMAVIC's main competitors?

Direct peers on record are Virbac, Vetoquinol, Ceva Santé Animale, Hipra, Dechra Pharmaceuticals, Norbrook Laboratories and Phibro Animal Health. Broad incumbents are Zoetis, Elanco Animal Health and Boehringer Ingelheim Animal Health.

Does DIVASA-FARMAVIC have an API?

No public API is recorded for DIVASA-FARMAVIC.

What industry is DIVASA-FARMAVIC in?

DIVASA-FARMAVIC's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAB, Livestock & Production Animal Therapeutics (Rx), with a secondary code of AFACADAF, Diagnostics & Laboratory Services (Sampling, Necropsy, Disease Investigation). Its NAICS code is 54194 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales